U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07306260) titled 'Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2' on Dec. 14.
Brief Summary: This study evaluates the efficacy and safety of ALA-PDT versus LEEP in treating cervical HSIL/CIN2, aiming to demonstrate non-inferiority in clinical efficacy.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
HSIL, High Grade Squamous Intraepithelial Lesion
CIN 2
HPV (Human Papillomavirus)-Associated
Photodynamic Therapy (PDT)
Intervention:
PROCEDURE: ALA-PDT
Apply 20% ALA gel for 3 hours, followed by red light irradiation, repeated every 7-14 days for a total of 6-9 session...